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SUMMARY 
 
As the central pacemaker in mammals, the circadian clock in the suprachiasmatic nucleus 
(SCN) of the hypothalamus is a heterogeneous structure consisting of multiple types of 
GABAergic neurons with distinct chemical identities [1, 2]. Although individual cells have 
a cellular clock driven by autoregulatory transcriptional/translational feedback loops of 
clock genes, interneuronal communication among SCN clock neurons is likely essential for 
the SCN to generate a highly robust, coherent circadian rhythm [1]. However, neuronal 
mechanisms that determine circadian period length remain unclear. The SCN is composed 
of two subdivisions: a ventral core region containing vasoactive intestinal peptide 
(VIP)-producing neurons and a dorsal shell region characterized by arginine vasopressin 
(AVP)-producing neurons. Here, we examined whether AVP neurons act as pacemaker cells 
that regulate the circadian period of behavior rhythm in mice. The deletion of casein kinase 
1 delta (CK1G) specific to AVP neurons, which was expected to lengthen the period of 
cellular clocks [3-6], lengthened the free-running period of circadian behavior as well. 
Conversely, the overexpression of CK1G specific to SCN AVP neurons shortened the 
free-running period. PER2::LUC imaging in slices confirmed that cellular circadian periods 
of the SCN shell were lengthened in mice without CK1G in AVP neurons. Thus, AVP 
neurons may be an essential component of circadian pacemaker cells in the SCN. 
Remarkably, the alteration of the shell–core phase relationship in the SCN of these mice did 
not impair the generation per se of circadian behavior rhythm, thereby underscoring the 
robustness of the SCN network. 
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RESULTS 
CK1G deficiency in AVP neurons lengthens, while its overexpression shortens, the 
free-running period of circadian behavior rhythm 
To test whether AVP neurons actively work as pacemaker cells to regulate the circadian 
period in mice, we assessed whether genetic manipulations of CK1G expressions in AVP 
neurons alter the period of behavior rhythm. In doing so, we acknowledged that the 
phosphorylation of PER proteins by CK1G might enhance those proteins’ degradation and 
consequently accelerate the speed of cellular clocks [7-13]. Indeed, the deletion of CK1G 
has been reported to lengthen periods of PER2::LUC oscillation by 1.5–3 hr [3-6]. 
To generate mice lacking functional CK1G specifically in AVP neurons, we 
crossed Avp-Cre mice [14] that express improved Cre recombinase specifically in AVP 
neurons with mice carrying floxed CK1G alleles (CK1Gflox2/flox2) [3], hereafter designated as 
Avp-CK1G-/- mice. In 12 hr of light and 12 hr of darkness (LD), Avp-CK1G-/- mice showed 
diurnal rhythm of spontaneous locomotor activity comparable to control mice 
(CK1Gflox2/flox2 and Avp-Cre;CK1G+/flox2 mice) (Figure 1;  Tables S1 and S2). By contrast, in 
constant darkness (DD), Avp-CK1G-/- mice free-ran with a period approximately 50 min 
longer than that of control mice (24.72 ± 0.03 hr versus 23.94 ± 0.03 hr, p < 0.001), while 
their activity time remained normal (13.96 ± 0.19 hr versus 13.42 ± 0.21 hr, p = 0.231). 
Conversely, Avp-CK1G-/- mice with CK1G overexpression in the SCN AVP 
neurons (Avp-CK1G-/-+AAV-DIO-CK1G mice)—achieved via focal injection of 
Cre-dependent adeno-associated viral (AAV) expression vectors in adult mice—free-ran 
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with a period approximately 30 min shorter than that of control mice (23.46 ± 0.06 hr, p < 
0.001) (Figures 1 and S1; Table S2). The depression of activity level in 
Avp-CK1G-/-+AAV-DIO-CK1G mice were likely due to AAV injections, because that was 
observed also in control mice for the surgery (Avp-CK1G-/-+AAV-DIO-mCherry mice, Table 
S2). 
Collectively, the manipulation of CK1G expression levels in AVP neurons of the 
SCN bidirectionally changed the free-running period of behavior rhythm. 
 
Avp-CK1G-/- mice respond to an 8-hr phase advance of the LD cycle by delaying their 
behavior rhythm 
When the 8-hr phase advance of LD cycle was given, in clear contrast to control mice (8 of 
8 mice), the Avp-CK1G-/- mice reentrained to the new LD cycle by delaying their activity 
rhythm (7 of 7 mice) (Figure S2A). The number of days required for reentrainment was 
significantly fewer in Avp-CK1G-/- mice when the LD cycle was advanced but not when it 
was delayed (phase advance: 8.25 ± 0.41 days versus 11.75 ± 0.90 days, p < 0.01; phase 
delay: 5.71 ± 0.47 days versus 5.62 ± 0.32 days, p = 0.876) (Figure S2B). This result was 
consistent with the lengthened circadian period of Avp-CK1G-/- [15, 16]. 
The phase-shifts of activity rhythms evoked by light pulses at CT14 and CT22 
were comparable between control and Avp-CK1G-/- mice (Figures S2H and S2I). 
 
Spatiotemporal pattern of gene expression changes in the SCN of Avp-CK1G-/- mice 
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We next evaluated the status of the molecular clock in the SCN by way of in situ 
hybridization (Figure 2). In the SCN of control mice, as expected, Avp mRNA was 
expressed predominantly in the shell and showed clear circadian expression, with a peak at 
approximately 20 hr in darkness (i.e., around CT8). The peak level of Avp mRNA 
expression in Avp-CK1G-/- mice was similar to that in control mice. However, the increase 
in expression was significantly delayed in Avp-CK1G-/- mice. The peak level of Per1 mRNA 
expression, which is a core component of circadian clocks, was also similar between two 
groups in both the SCN shell and core. Intriguingly, the increase of Per1 expression in the 
shell was significantly delayed relative to that of the core in Avp-CK1G-/- mice. The clearest 
difference occurred at 16 hr in darkness (i.e., around CT4) (Figure 2B). Thus, the 
CK1Gdeletion specific to AVP neurons might reorder the spatiotemporal pattern of gene 
expression in the SCN. The delay of gene expression in the shell of Avp-CK1G-/- mice was 
consistent with the presumed lengthening of cellular periods in AVP neurons. 
 
Deletion of CK1Gin AVP neurons lengthens cellular periods of the SCN shell and 
alters the spatiotemporal order of PER2::LUC oscillations in the SCN 
Because Avp-CK1G-/- mice free-ran with a coherently lengthened period, we expected that 
the cellular clocks of the entire SCN would also oscillate with a lengthened period. To test 
this hypothesis, we performed real-time bioluminescent cell imaging of coronal SCN slices 
prepared from control and Avp-CK1G-/- adult mice with a luciferase reporter (Per2::Luc) 
[17] housed in DD (Figures 3 and S3A; Table S3). Contrary to our expectations, the SCN 
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shell and core of Avp-CK1G-/-;Per2::Luc mice transiently showed different cellular periods 
ex vivo (Figures 3A and 3C). The period of the shell was longer by approximately 2 hr at 
the beginning (shell: 25.91 ± 0.50 hr versus core: 23.73 ± 0.07 hr, p < 0.001) (Figure 3C 
and Table S3). However, this lengthening did not continue into the next cycle (shell: 23.65 
± 0.33 hr versus core: 23.98 ± 0.06 hr, p = 0.343). Accordingly, the peak time of 
PER2::LUC oscillation in the shell was later relative to that of the core at the first peak in 
Avp-CK1G-/-;Per2::Luc mice (Figures 3A and 3D). This delay increased at the second peak, 
but did not increase any further in subsequent cycles. The peak amplitude of PER2::LUC 
oscillation was significantly lower and decayed more rapidly in the SCN shell of 
Avp-CK1G-/-;Per2::Luc mice (Figures 3A and 3E; Table S3). These data suggest that 
intercellular communications between the shell and core somehow precluded the 
lengthening of shell’s period in the prolonged culture. 
 We expected that blocking intercellular communications by the application of 
tetrodotoxin (TTX), a blocker of voltage-dependent sodium channels, would allow the core 
and shell regions to each express their endogenous period lengths ex vivo [18, 19]. 
Surprisingly, however, the transient period difference, followed by period length 
synchronization, persisted despite the application of TTX in the SCN slices of 
Avp-CK1G-/-;Per2::Luc mice (Figures S3B and S4A-D; Table S3). 
By extension, we aimed to reduce intercellular communications between the core 
and shell by surgically cutting the SCN slice along the horizontal plane (Figures 3B, S3C, 
and S3D; Table S3). In slices with knife cuts, the lengthened period of the SCN shell in 
Avp-CK1G-/- mice was maintained for a longer duration (Figure 3F and Table S3). 
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Accordingly, the peak time difference of PER2::LUC oscillation between the shell and core 
increased lineally for three cycles (Figure 3G). This result suggested that the core sent a 
signal that modulated the shell in the SCN slices, which was attenuated by surgical cuts 
between the regions. Such data indicate that the periods of cellular clocks in the SCN shell 
were lengthened in Avp-CK1G-/- mice by 1.4–2 hr. 
To increase the resolution of circadian rhythm analysis, we applied a cosine 
curve-fitting method on PER2::LUC oscillations in individual pixels that covered the SCN 
(Figures 4 and S4E–G; Table S4)[20]. The periods of pixels in the shell were lengthened in 
Avp-CK1G-/- mice, which was more obvious in slices with surgical cuts (Figures 4A, 4C and 
S4E). In control mice, we observed phase-leading cells (i.e., pixels) located dorsomedially 
[19], whose first acrophase (peak phase) was advanced relative to other pixels. However, 
such phase-leading cells were not clearly found in Avp-CK1G-/- mice. Raster plots of signal 
intensity across the SCN further demonstrated that dorsomedial pixels were 
phase-advanced in control mice, whereas those in Avp-CK1G-/- mice were obviously 
phase-delayed relative to the pixels in the core (Figures 4B, 4D and S4F). The phase delay 
continued to increase in slices with surgical cuts, yet not in intact or TTX-treated slices, as 
observed in ROI analyses described above (Figures 3 and S4). These data suggest that the 
spatiotemporal pattern of PER2::LUC oscillation throughout the SCN was altered in 
Avp-CK1G-/- mice, a conclusion consistent with results of gene expression in vivo elucidated 
by in situ hybridization (Figure 2). 
The mean period of individual pixel oscillations was significantly lengthened by 
2–2.5 hr in the shell of Avp-CK1G-/- mice (Figures 4E, 4F and S4G; Table S4). Interestingly, 
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when the cumulative frequency of the pixel periods was plotted, we found a peak of pixels 
with normal periods in slices with surgical cuts, which was smoothed in intact and 
TTX-treated slices (Figures 4E, 4F, and S4G). This peak might represent non-AVP neurons 
and a small number of AVP neurons that sustain an undeleted CK1G allele. This observation 
further supported a notion that the intercellular interaction modified the cellular periods of 
the shell. The mean first acrophase of the individual pixel oscillations was delayed in the 
shell by 2–3 hr compared to that of the core (Figures 5E, 5F, S4G, and Table S4). It should 
be noted that TTX application indeed altered some aspects of the SCN network property, 
such as the first acrophase of pixels in the core of both control and Avp-CK1G-/- mice 
(Figure S4G). 
Collectively, these data suggest that periods of cellular clocks in the SCN shell 
were lengthened in Avp-CK1G-/- mice by roughly 2 hr, which altered the spatiotemporal 
pattern of PER2::LUC oscillation across the SCN. 
 
DISCUSSION 
We recently demonstrated that mice with a Bmal1 deletion specific to AVP neurons 
(Avp-Bmal1-/- mice) showed marked lengthening and instability in the free-running period 
and activity time of behavior rhythm [14]. This result suggested that cellular clocks in AVP 
neurons are required for the appropriate, stable expression of the circadian period by 
enhancing the coupling of SCN neurons. However, the relative contribution of the loss of 
synchronizing signals versus the loss of rhythmicity in AVP neurons was inseparable. By 
extension, the present study provides clear evidence that AVP neurons indeed regulate SCN 
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pacemaking. It is unlikely that the AVP peptide solely mediates this effect, because a 
deficiency of AVP signaling does not change the free-running period in mice or rats [21, 22]. 
Interestingly, the alteration of the shell–core phase relationship did not impair the 
generation per se of behavioral circadian rhythm, thereby indicating the robustness of the 
SCN network. It should be emphasized that the circadian phenotype of Avp-Bmal1-/- mice 
was not identical to that of Avp-CK1G-/- mice, making it unlikely that CK1Gdeletion 
disrupted the cellular clock beyond simply altering the period. 
Wild-type↔Clock∆19/∆19 mutant chimera mice in which random subsets of 
wild-type SCN cells were replaced with Clock∆19/∆19 cells demonstrated a number of 
intermediate circadian phenotypes [23]. Notably, their circadian period and amplitude were 
highly labile, which contrasted those of Avp-CK1G-/- mice. Such a qualitative difference 
may indicate a specialized role for AVP neurons in SCN pacemaking. 
Lee et al. employed an approach similar to ours. They demonstrated that the 
free-running period of behavior was extended by lengthening the cellular period of 
neuromedin S (NMS)-producing neurons by way of the overexpression of Clock∆19 [24]. 
NMS neurons represent a heterogenous population with AVP and VIP neurons, among other 
neuronal types [24]. Surprisingly, overexpression of the Clock∆19 transgene in VIP neurons 
had no effect on the behavioral free-running period [24]. Indeed, VIP has been 
demonstrated to be especially important for the maintenance and synchronization of 
cellular clocks in individual SCN neurons [25-28]. 
More recently, Smyllie et al. created chimeric mice with SCN containing 
dopamine 1a receptor (Drd1a) cells with an intrinsic cellular period of 24 hr alongside 
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non-Drd1a cells with a period of 20 hr [18]. Remarkably, 60% of chimeric mice showed 
24-hr periods of behavior and SCN PER2::LUC rhythms, whereas 33% showed 20-hr 
periods. Moreover, the chimeric SCN sustained a wave of PER2::LUC bioluminescence 
comparable to that of nonchimeric SCN. These characteristics contrast starkly with those of 
Avp-CK1G-/- mice. Drd1a cells contain 63% of all SCN cells, including 62% of AVP 
neurons and 81% of VIP neurons, though <1% of GRP neurons [18]. Therefore, the slight 
difference in the ratio of 24-hr AVP neurons to 20-hr AVP neurons could exert a substantial 
impact on the period with which the chimeric SCN oscillates. However, our results suggest 
that AVP neurons alone cannot set the normal spatiotemporal order of circadian oscillation 
across the entire SCN. Accordingly, AVP neurons might need to work in concert with other 
types of neurons to reorganize the entire SCN network. In contrast to AVP neurons, as Lee 
et al. and Smyllie et al. both indicated, genetic manipulations that lengthen the cellular 
period in most VIP neurons do not change the speed of the SCN. Cellular clocks in VIP 
neurons and other types of non-AVP neurons might stabilize the circadian oscillation of the 
entire SCN, which could support the robustness of the network. 
PER2::LUC imaging suggested that cells in the SCN shell oscillated with periods 
of roughly 26 hr, whereas those in the core oscillated with periods of roughly 24 hr in 
Avp-CK1G-/- mice. However, the intrinsic period of the cellular clocks in AVP neurons 
measured in this study might be imprecise. Although AVP neurons represented the SCN 
shell, it also contained non-AVP neurons. Intercellular communications could have further 
affected the period of AVP neurons. Nevertheless, the roughly 2-hr difference of periods 
between shell and core oscillations concurs with values reported for CK1G–deficient cells 
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[3-6]. Unfortunately, we have no information concerning the behavioral free-running period 
of CK1G-/- mice, which died perinatally [3]. The behavioral free-running period of 
Avp-CK1G-/- mice was ~25 hr or between cellular periods of the SCN shell and core 
estimated from PER2::LUC imaging. Thus, coupling between AVP neurons and non-AVP 
neurons is likely to occur in vivo in determining the free-running period. 
In this context, it is notable that surgical cuts between the shell and core 
stabilized the lengthened period of the shell in SCN explants of Avp-CK1G-/- mice, which 
implied a modulatory influence of the core on the period of the shell (Figures 3 and 4). 
Collectively, the core and shell may be held together in vivo by coupling, which is slightly 
less effective ex vivo, and thereby allow the core and shell to oscillate independently. 
During prolonged culture, the core and shell might settle into a new steady state with a 
stable period and phase relationship by way of intercellular communications. The 
emergence of a novel steady state of circadian oscillation in prolonged culture was also 
reported, even for the SCN of Bmal1-deficient mice [29]. Consequently, the intact structure 
of the SCN or its connections with extra-SCN regions, if not both, might be indispensable 
for such coupling in vivo, as our previous study implied [14]. The oscillation in the shell of 
Avp-CK1G-/- mice was dampened rapidly ex vivo (Figures 3, 4E and S4), whereas that in 
vivo did not show a reduction in its amplitude (Figure 2). This fact may suggest that the 
core-to-shell connection might be resistant while the shell-to-core connection might be 
more susceptible to slicing. 
Surprisingly, TTX application did not erase the core’s modulatory influence on 
the PER2::LUC period of the shell, for TTX is thought to disrupt interneuronal 
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communication [18, 19]. In fact, TTX application altered some aspects of PER2::LUC 
oscillations (Figure S4). We used SCN explants prepared from adult mice. Compared to 
SCN explant cultures from neonates [18, 19], SCN cultures from adults have shown gene 
expression with a far less drastic effect of TTX treatment [30]. Differences in the network 
properties of neonatal and adult SCN have been also reported [31]. Therefore, both sodium 
spike-dependent and -independent mechanisms of interneuronal communication are 
possible in the SCN of adult mice [32].  
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EXPERIMENTAL PROCEDURES 
Animals 
To generate Avp-CK1G-/- mice, Avp-Cre mice [14] were mated to mice with a conditional 
CK1G allele (CK1Gflox2) [3]. All experimental procedures involving animals were approved 
by the appropriate institutional animal care and use committee of Kanazawa University. 
 
Behavioral Analyses 
Male and female Avp-CK1G-/- (Avp-Cre;CK1Gflox2/flox2) and control (CK1Gflox2/flox2 and 
Avp-Cre;CK1G+/flox2) mice were housed individually in a cage placed in a light-tight 
chamber. Spontaneous locomotor activity was monitored by infrared motion sensors in 




The Avp-CK1G1-/- mice were further mated with Per2::Luc reporter mice [17]. Mice were 
housed in DD for 6 days before sampling. Coronal SCN slices of 150 µm were cultured as 
described previously with slight modifications [33]. Images were acquired every 30 min 
and were analyzed using ImageJ and custom-made program [20]. 
 
SUPPLEMENTAL INFORMATION 
Supplemental Information includes Supplemental Experimental Procedures, four figures, 
and four tables. 
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FIGURE LEGENDS 
Figure 1. Avp-CK1G-/- mice show lengthening of the free-running period in DD. (A) 
Representative locomotor activity of control, Avp-CK1G-/-, and Avp-CK1G-/- mice 
overexpressing CK1Gin SCN AVP neurons (Avp-CK1G-/-+AAV-DIO-CK1G). Gray shading 
indicates the time when lights were off. (B) Daily profile of locomotor activity in LD or 
DD. (C) Free-running period was lengthened in Avp-CK1G-/- mice and was shortened in 
Avp-CK1G-/-+AAV-DIO-CK1G mice. Error bars indicate S.E.M; n = 14 for control, n = 13 
for Avp-CK1G-/- mice, and n = 8 for Avp-CK1G-/-+AAV-DIO-CK1G mice; ***, p < 0.001 
versus control; ^^^, p < 0.001 versus Avp-CK1G-/-. (D) Representative images of mCherry 
expression in the SCN of Avp-CK1G-/-+AAV-DIO-CK1G mice injected with a mixture of 
recombinant AAV vectors expressing CK1G or mCherry in a Cre-dependent manner. Scale 
bars, 500 μm for left panel; 100 μm for right magnified panel. HDB, nucleus of the 
horizontal limb of the diagonal band; SON, supraoptic nucleus. See also Figures S1 and S2; 
Tables S1 and S2. 
 
Figure 2. Circadian gene expression is delayed in the shell of SCN in Avp-CK1G-/- mice. 
(A) Representative images of Avp and Per1 mRNA expression in the SCN of control and 
Avp-CK1G-/- mice at times indicated in darkness after the onset of the last dark phase (“12 
hr” corresponds roughly to CT0). Coronal brain sections were hybridized in situ to an 
antisense probe for each gene. Scale bar, 100 µm. (B) Circadian expression of each gene in 
the middle SCN along the rostro-caudal axis. Expression was quantified for the entire 
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section (Avp) or separately for the shell and core (Per1). Representative regions defined as 
the shell and core SCN are indicated by yellow circles in (A). Error bars indicate S.E.M; n 
= 6. g, effect of genotype in each region; r, effect of region in each genotype; by post hoc 
pairwise comparisons; lowercase, p < 0.01; italicized lowercase, p < 0.05. 
 
Figure 3. The period of cellular circadian oscillation is lengthened in the shell of SCN in 
Avp-CK1G-/- mice. (A) Representative images of PER2::LUC expression. Coronal SCN 
slices of the mid-rostrocaudal region were prepared from adult control and Avp-CK1G-/- 
mice with a luciferase reporter (Per2::Luc) housed in DD. Detrended bioluminescence 
within the two shell and two core regions indicated in the images were plotted on the right. 
Gray vertical lines labeled “Day 1” indicate 15 hr after the start of image recordings around 
CT9. (B) SCN slices received surgical cuts along the horizontal plane, shown by arrows in 
the bright-field images on the left. (C, F) Periods of PER2::LUC oscillations for two cycles 
defined in (A). (D, G) Peak time differences between the shell and core of the SCN. (E, H) 
Amplitudes of the three peaks defined in (A). Data of SCN slices without (C–E) or with 
(F–H) surgical cuts. The period was clearly lengthened in the SCN shell of 
Avp-CK1G-/-;Per2::Luc mice when slices received surgical cuts. Error bars indicate S.E.M; 
n = 5 for control, n = 7 (C–E) or 5 (F–H) for Avp-CK1G-/-;Per2::Luc mice. For (C, D, F, G), 
G, effect of genotype in each region for each cycle; R, effect of region in each genotype for 
each cycle; C, effect of cycle (versus 2nd) in each region of each genotype; by post hoc 
pairwise comparisons. For (E, H), G, effect of genotype in the shell; R, effect of region in 
Avp-CK1G-/- mice; G x C, interaction between genotype and cycle in the shell; R x C, 
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interaction between region and cycle in Avp-CK1G-/- mice; by two-way repeated-measures 
ANOVA; uppercase, p < 0.001; lowercase, p < 0.01; italicized lowercase, p < 0.05. See also 
Figures S3 and S4; Table S3. 
 
Figure 4. Spatiotemporal pattern of PER2::LUC oscillation is altered in the SCN of 
Avp-CK1G-/- mice. (A, C) Representative amplitude, period, and first acrophase maps of 
PER2::LUC oscillation at the pixel level of intact (A) or surgically cut (C) SCN slices 
shown in Figure 3. Amplitudes, periods, and acrophases of PER2::LUC oscillations in the 
individual pixels covering the SCN were calculated by cosine curve fittings for data 
representing 72 hr from the first CT6 after slice preparation, determined according to 
behavioral free-running period before slice preparation. For the first acrophase, “6 hr” 
corresponds to the beginning of cosine curved-fitted data at roughly CT6. (B, D) Raster 
plots of signal intensity from the dorsal tip to the end of ventral region as indicated by red 
lines in (A) and (C). (E, F) Mean and cumulative frequency of amplitude, period and first 
acrophase of individual pixels’ PER2::LUC oscillations. Cumulative frequency plots show 
the distribution of pixels’ periods and first acrophases. The dorsal 40% and ventral 30% 
regions of the SCN were regarded as the shell and core, respectively. Representative 
regions defined as the SCN shell or core are indicated in (A) and (C). Data of SCN slices 
without (E) or with (F) surgical cuts. Error bars indicate S.E.M; n = 5 for control, n = 7 (E) 
or 5 (F) for Avp-CK1G-/-;Per2::Luc mice. G, effect of genotype in each region; R, effect of 
region in each genotype; by post hoc pairwise comparisons; uppercase, p < 0.001; 
lowercase, p < 0.01; italicized lowercase, p < 0.05. See also Figures S3 and S4; Table S4. 
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Figure S1. Distributions of CK1δ–overexpressing cells in Avp-CK1δ-/-+AAV-DIO-CK1δ mice, related to 
Figure 1. Mixture of recombinant AAV vectors expressing CK1δ or mCherry in a Cre-dependent manner by 
means of DIO (double-floxed inverse open reading frame)/FLEX (flip-excision) switch was focally injected 
into the SCN. The ratio of AAV-DIO-CK1δ to AAV-DIO-mCherry was 5:1. (A) Representative images of 
slices prepared from 8 individual Avp-CK1δ-/-+AAV-DIO-CK1δ mice and stained with anti-DsRed antibody 
to detect mCherry expression are shown. The free-running period of each mouse is indicated in parentheses. 
In addition to the SCN, some off-target expression was observed in a small number of scattered neuronal cell 
bodies and fibers in the supraoptic nucleus (SON), paraventricular hypothalamic nucleus (PVH), and nucleus 
of the horizontal limb of the diagonal band (HDB) of most mice as well as in the thalamic reticular nucleus 
(TRN) and zona incerta (ZI) of a few mice. Note that mCherry+ cells were almost completely restricted to the 
SCN in mouse #4 whose free-running period was still shorter (23.48 hr) as compared to those of control mice. 
(B) Representative images of CK1δ mRNA expression in the SCN of control 
(Avp-CK1δ-/-+AAV-DIO-mCherry) and Avp-CK1δ-/-+AAV-DIO-CK1δ mice. Coronal sections were 
hybridized in situ to an antisense probe for CK1δ. Under the condition used in the current study, CK1δ mRNA 
expression was lower than the detection limit in control mice, while it was clearly observed in the shell of the 
SCN in Avp-CK1δ-/-+AAV-DIO-CK1δ mice. 
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Figure S2. Avp-CK1δ-/- mice reentrain to the 8-hr phase advance of LD cycle by delaying their behavior 
rhythm, related to Figure 1. (A) Representative locomotor activity of control and Avp-CK1δ-/- mice. All 
control mice (8 of 8) advanced their activity rhythm, while all Avp-CK1δ-/- mice (7 of 7) delayed, upon 8-hr 
phase advance of LD cycle. (B) The number of days required for reentrainment to the 8-hr phase advance was 
reduced in Avp-CK1δ-/- mice. Error bars indicate S.E.M. **, p < 0.01. (C, D) Daily profiles of locomotor 
activity during the days indicated by vertical bars on the right side of the actogram. The phase angle of 
entrainment in Avp-CK1δ-/- mice was delayed in new LD cycles. (E) LD cycle was phase-advanced for 8 hr in 
a way different from (A): the light phase was shortened at the beginning of phase shift (day 11, indicated by 
arrows). Although as unclear as in (A), all Avp-CK1δ-/- mice (4 of 4) delayed their activity rhythm with an 
8-hr phase advance. (F) The number of days required for reentrainment to the 8-hr phase advance in (E) was 
reduced in Avp-CK1δ-/- mice. *, p < 0.05. (G) Daily profiles of locomotor activity during the days indicated 
by vertical bars on the right side of the actogram in (E). In this experiment, significant delay of the phase 
angle of entrainment was not observed in Avp-CK1δ-/- mice. (H) Phase-shifting responses to light are 
unchanged in Avp-CK1δ-/- mice. Representative locomotor activity of control and Avp-CK1δ-/- mice are shown. 
Mice were given a 30 min light pulse at CT14 or CT22 as indicated by yellow stars on actograms. (I) Phase 




Figure S3. Spatiotemporal pattern of PER2::LUC oscillation is altered in the SCN of Avp-CK1δ-/- mice, 
related to Figure 3. (A-C) Representative bioluminescence recording from intact (A), TTX-treated (B), or 
surgically cut (C) SCN slices. “6 hr” corresponds to the first CT6 after slice preparation, determined 
according to behavioral free-running period before slice preparation. (D) SCN explants with surgical cuts 
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Figure S4. Effect of TTX on PER2::LUC oscillation, related to Figures 3 and 4. (A) Coronal SCN slices of 
the mid-rostrocaudal region were cultured with 2.5 µM TTX. Detrended bioluminescence within the two shell 
and two core regions as indicated in Figure 3A were plotted. Gray vertical lines labeled “Day 1” indicate 15 
hr after the start of image recordings around CT9. (B) Period of PER2::LUC oscillations for two cycles 
defined in (A). (C) Peak time differences between the shell and core of the SCN. (D) Amplitudes of the three 
peaks defined in (A). Error bars indicate S.E.M; n = 5 for control, n = 6 for Avp-CK1δ-/-;Per2::Luc mice. 1 
µM TTX was applied for two control and three Avp-CK1δ-/- slices, while 2.5 µM TTX was applied for the rest. 
Because the effects of two concentrations were similar, we processed two groups together. For (B, C), G, 
effect of genotype in each region for each cycle; R, effect of region in each genotype for each cycle; C, effect 
of cycle in each region of each genotype; by post hoc pairwise comparisons. For (D), G, effect of genotype in 
the shell; R, effect of region in Avp-CK1δ-/- mice; R x C, interaction between region and cycle in Avp-CK1δ-/- 
mice; by two-way repeated-measures ANOVA; uppercase, p < 0.001; lowercase, p < 0.01; italicized 
lowercase, p < 0.05. (E) Representative amplitude, period, and first acrophase maps of PER2::LUC oscillation 
at the pixel level of TTX-treated SCN slices. Amplitudes, periods, and acrophases of PER2::LUC oscillations 
in the individual pixels covering the SCN were calculated by cosine curve fittings for data representing 72 hr 
from the first CT6 after slice preparation, determined according to behavioral free-running period before slice 
preparation. For the first acrophase, “6 hr” corresponds to the beginning of cosine curved-fitted data at 
roughly CT6. (F) Raster plots of signal intensity from the dorsal tip to the end of ventral region as indicated 
by red lines in (E). (G) Mean and cumulative frequency of period and first acrophase of individual pixels’ 
PER2::LUC oscillations. The dorsal 40% and ventral 30% regions of the SCN were regarded as the shell and 
core, respectively. Representative regions defined as the SCN shell or core are indicated in (E). n = 5 for 
control, n = 6 for Avp-CK1δ-/-;Per2::Luc mice. G, effect of genotype in each region; R, effect of region in 
each genotype; by post hoc pairwise comparisons; uppercase, p < 0.001; lowercase, p < 0.01; italicized 




Table S1. Comparison of two genotypes regarded as control 
Genotype CK1δflox2/flox2 Avp-Cre;CK1δ+/flox2 
n  10 4 
Light-Dark (7 days)   
 Amplitude (Qp) 3466.14 ± 195.78 3924.64 ± 437.24 
 Activity time (hr) 12.49 ± 0.16 12.76 ± 0.16 
 Activity onset (ZT) 12.09 ± 0.02 12.01 ± 0.03 
 Activity offset (ZT) 0.59 ± 0.15 0.77 ± 0.14 
 Activity (count)   
    Dark period 16427 ± 1099 20247 ± 5198 
  Light period 3365 ± 207 3538 ± 576 
    24 hr 19792 ± 1182 23785 ± 5771 
Constant Darkness (days 5-19)  
 Amplitude (Qp) 6377.61 ± 347.14 5942.62 ± 499.40 
 Free-running period (hr)  
    Periodogram 23.92 ± 0.03 24.00 ± 0.04 
    Visual inspection   
      Activity onset 23.89 ± 0.03 23.99 ± 0.04 
      Activity offset 23.93 ± 0.03 24.00 ± 0.06 
 Activity time (circadian hr)  
    Activity profile 13.30 ± 0.25 13.73 ± 0.39 
    Visual inspection 13.09 ± 0.25 13.76 ± 0.32 
 Cycle-to-cycle variability (SD) (min) – Visual inspection 
    Activity onset 13.98 ± 0.68 14.70 ± 1.26 
    Activity offset 37.14 ± 3.75 34.05 ± 3.27 
 Activity (count)   
    Activity period 18602 ± 1009 21000 ± 3880 
    Rest period 2670 ± 239 2394 ± 641 
    Free-running period 21302 ± 1147 23394 ± 4488 
 
Table S1. Comparison of two genotypes regarded as control. Significant differences between CK1δflox2/flox2 
and Avp-Cre;CK1δ+/flox2 mice were not detected in any parameters by Student’s t tests. 
 
  
Table S2. Phenotypic Characteristics of Avp-CK1δ-/- Mice 
Genotype Control Avp-CK1δ-/- Avp-CK1δ-/- + Avp-CK1δ-/- + 
    AAV-DIO-CK1δ AAV-DIO-mCherry 
n  14 13 8 6 
Light-Dark (7 days)    
 Amplitude (Qp) 3597.14 ± 186.71 3847.11 ± 158.63 3346.14 ± 230.33 3685.99 ± 182.44 
 Activity time (hr) 12.57 ± 0.12 12.76 ± 0.19 12.19 ± 0.18 11.99 ± 0.07*^^ 
 Activity onset (ZT) 12.07 ± 0.02 12.32 ± 0.10 12.03 ± 0.09 12.49 ± 0.15 
 Activity offset (ZT) 0.64 ± 0.12 1.07 ± 0.19 0.22 ± 0.20^ 0.48 ± 0.13 
 Activity (count)    
    Dark period 17519 ± 1615 16028 ± 1168 14473 ± 896 15274 ± 1809 
    Light period 3414 ± 209 4565 ± 427 2622 ± 450^ 2924 ± 499^ 
    24 hr 20933 ± 1771 20594 ± 1360 17095 ± 1237 18199 ± 1657 
Constant Darkness (days 5-19)   
 Amplitude (Qp) 6253.33 ± 281.08 7366.32 ± 395.38 5311.47 ± 537.70 5644.51 ± 409.46 
 Free-running period (hr)   
    Periodogram 23.94 ± 0.03 24.72 ± 0.03*** 23.46 ± 0.06***^^^ 24.52 ± 0.04**^# 
    Visual inspection   
  Activity onset 23.91 ± 0.03 24.70 ± 0.03*** 23.39 ± 0.05***^^^ 24.50 ± 0.04**^# 
  Activity offset 23.95 ± 0.03 24.78 ± 0.02*** 23.46 ± 0.06***^^^ 24.56 ± 0.04**^# 
 Activity time (circadian hr)   
    Activity profile 13.42 ± 0.21 13.96 ± 0.19 13.73 ± 0.30 12.73 ± 0.22^ 
    Visual inspection 13.32 ± 0.21 13.94 ± 0.19** 13.00 ± 0.37^ 12.90 ± 0.19^ 
 Cycle-to-cycle variability (SD) (min) – Visual inspection 
    Activity onset 14.19 ± 0.58 20.49 ± 2.21* 21.68 ± 2.22* 16.70 ± 2.64 
    Activity offset 36.26 ± 2.79 30.37 ± 2.55 30.08 ± 3.93 24.50 ± 2.64 
 Activity (count)    
    Activity period 19287 ± 1260 22145 ± 1189 13580 ± 706**^^ 13988 ± 1060*^^ 
    Rest period 2612 ± 238 2149 ± 192 1644 ± 211* 1830 ± 347* 
    Total 21900 ± 1431 24294 ± 1287 15224 ± 831**^^ 15818 ± 1236*^^ 
 
Table S2. Phenotypic characterization of Avp-CK1δ-/- mice, related to Figure 1. Control includes CK1δflox2/flox2 
and Avp-Cre;CK1δ+/flox2 mice. Values are mean ± S.E.M. For comparison between control, Avp-CK1δ-/-, 
Avp-CK1δ-/-+AAV-DIO-CK1δ, and Avp-CK1δ-/-+AAV-DIO-mCherry (control for AAV injection) mice, 
effects of genotype were analyzed by Kruskal-Wallis tests followed by Steel-Dwass post hoc tests. *, versus 
control mice; ^, versus Avp-CK1δ-/- mice; #, versus Avp-CK1δ-/-+AAV-DIO-CK1δ mice; one letter, p < 0.05; 
two letters,, p < 0.01; three letters, p < 0.001. 
 
   




Region Shell Core Shell Core
Period (hr)
1st cycle 23.95 ± 0.08 24.00 ± 0.08 25.91 ± 0.50g, r, C 23.72 ± 0.07
2nd cycle 23.85 ± 0.08 24.07 ± 0.06 23.65 ± 0.33 23.98 ± 0.06
Peak time difference (hr)
1st peak 0.32 ± 0.13 -2.02 ± 0.29G, c
2nd peak 0.37 ± 0.26 -4.21 ± 0.74G
3rd peak 0.59 ± 0.26 -3.31 ± 1.12g
Peak amplitude (RLU)
1st peak 59.28 ± 9.91c 55.34 ± 9.36c 31.57 ± 1.69g, r, c 45.42 ± 3.19c
2nd peak 52.82 ± 10.98 44.87 ± 7.74 14.27 ± 1.48g, R 36.87 ± 2.89




Region Shell Core Shell Core
Period (hr)
1st cycle 23.78 ± 0.14 23.81 ± 0.12 24.44 ± 0.27r, c 23.55 ± 0.07
2nd cycle 23.87 ± 0.08 24.02 ± 0.08 23.15 ± 0.46 23.69 ± 0.08
Peak time difference (hr)
1st peak 0.98 ± 0.13 -1.99 ± 0.39G
2nd peak 1.00 ± 0.20 -2.76 ± 0.55G
3rd peak 1.15 ± 0.17 -1.95 ± 0.62g
Peak amplitude (RLU)
1st peak 59.26 ± 7.72c 50.73 ± 4.03c 35.55 ± 3.24g,  c 43.08 ± 5.80c
2nd peak 47.89 ± 7.14 39.08 ± 4.23 18.03 ± 1.74g, r 35.97 ± 4.56




Region Shell Core Shell Core
Period (hr)
1st cycle 23.77 ± 0.10 23.86 ± 0.07 26.14 ± 0.38g, r 23.96 ± 0.08
2nd cycle 24.04 ± 0.17 24.10 ± 0.08 25.52 ± 0.48g, r 24.15 ± 0.13
Peak time difference (hr)
1st peak 0.20 ± 0.29 -2.48 ± 0.47g, c
2nd peak 0.29 ± 0.36 -4.67 ± 0.64G
3rd peak 0.35 ± 0.46 -6.26 ± 1.18g, c
Peak amplitude (RLU)
1st peak 41.53 ± 7.12r, c 21.11 ± 3.59c 42.34 ± 3.13r,  c 23.36 ± 4.28
2nd peak 32.18 ± 6.39 18.71 ± 3.12 19.30 ± 1.67 18.14 ± 2.91
3rd peak 26.54 ± 5.93c 15.29 ± 2.87c 9.94 ± 1.56g, c 14.48 ± 2.65c
Table S3. Summary of PER2::LUC imaging studies (ROI analysis), related to Figure 3. Values are mean ± 
S.E.M. Two-way repeated-measures ANOVA was followed by post hoc tests as below. To compare the two 
groups, Student’s t tests or paired t tests were performed; Welch’s t test was used when the variances of the 
two groups differed significantly. To compare the three groups, Friedman tests followed by Wilcoxon 
signed-rank tests were performed. G, effect of genotype in each region for each cycle; R, effect of region in 
each genotype for each cycle; C, effect of cycle (versus 2nd) in each region of each genotype; by post-hoc 




Table S4. Summary of PER2::LUC imaging studies (pixel-based analysis), related to Figure 4. Values are 
mean ± S.E.M. Two-way repeated-measures ANOVA followed by post hoc Student’s t tests or paired t tests 
were performed; Welch’s t test was used when the variances of the two groups differed significantly. G, effect 
of genotype in each region; R, effect of region in each genotype; by post-hoc pairwise comparisons; 
uppercase, p < 0.001; lowercase, p < 0.01; italicized lowercase, p < 0.05. 
  




Region Shell Core Shell Core
Amplitude (RLU) 34.05 ± 6.49 32.92 ± 4.25 15.94 ± 0.79g, R 25.72 ± 1.52
Period (hr) 23.78 ± 0.07 23.92 ± 0.07 25.68 ± 0.27G, R 23.75 ± 0.11




Region Shell Core Shell Core
Amplitude (RLU) 27.81 ± 3.00 27.05 ± 1.60 14.85 ± 0.88g, r 24.13 ± 2.31
Period (hr) 23.63 ± 0.19 23.56 ± 0.13 24.33 ± 0.34g 23.39 ± 0.15




Region Shell Core Shell Core
Amplitude (RLU) 20.65 ± 3.36 15.76 ± 2.44 15.80 ± 0.74 15.09 ± 1.86
Period (hr) 23.99 ± 0.19 23.93 ± 0.06 26.59 ± 0.25G, R 23.92 ± 0.15
1st acrophase (hr) 5.66 ± 0.34 5.87 ± 0.26 7.05 ± 0.48g, r 4.51 ± 0.27g
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
Animals 
To generate Avp-CK1δ-/- mice, Avp-Cre mice [14] were mated to mice with a conditional CK1δ allele 
(CK1δflox2) [3] (N>12 backcrossed to C57BL/6J, The Jackson Laboratory # 010487). Mice were maintained 
under a strict 12-hour light:dark cycle in a temperature- and humidity-controlled room and fed ad libitum. All 
experimental procedures involving animals were approved by the appropriate institutional animal care and use 
committee of Kanazawa University. 
 
Behavioral Analyses 
Male and female Avp-CK1δ-/- (Avp-Cre;CK1δflox2/flox2) and control (CK1δflox2/flox2 and Avp-Cre;CK1δ+/flox2; 
because these two behaved similarly, we regarded them together as control, Table S1) mice, aged 6 to 19 
weeks, were housed individually in a cage placed in a light-tight chamber (light intensity was approximately 
50 lux). Spontaneous locomotor activity was monitored by infrared motion sensors (O’Hara) in 1-min bins. 
Actogram, activity profile, and χ2 periodogram analysis was performed via ClockLab (Actimetrics). The 
free-running period was measured by periodogram, as well as by visual inspection, for days 5-19 in DD. The 
activity time was calculated from the daily activity profile (average pattern of activity) of the same 15 days 
using the mean activity level as a threshold for detecting the onset and the offset of activity time [14], or by 
visual inspection. To determine the light-induced phase shift of locomotor activity, animals in their home 
cages free-running in DD were exposed to a 30-min pulse of white light (approximately 50 lux) at CT14 or 
CT22. The onset and end of nocturnal activity were determined by visual inspection on actograms for 
measuring light-induced phase shifts of activity and the number of days required for reentrainment after 
abrupt shifts in the LD cycles. 
 
Generation and focal injection of recombinant AAV vectors 
The AAV-2 ITR-containing plasmid pAAV-DIO-hChR2(H134R)-EYFP-WPRE-pA (provided by Dr. Karl 
Deisseroth) was modified to construct pAAV-EF1α-DIO-CK1δ by replacing hChR2(H134R) cDNA with 
mouse CK1δ (variant 1) cDNA fragment amplified by PCR from the plasmid pcFLAG-CK1δ [S1] (provided 
by Dr. Isamu Kameshita) using following primers: 5’- attgctagccaccATGgagctgagggtcgggaacagg-3’ and 5’- 
attggcgcgccTCAtcggtgcacgacagactgaag-3’. 
Recombinant AAV vectors expressing CK1δ (AAV-DIO-CK1δ) or mCherry (AAV- DIO-mCherry) 
in a Cre-dependent manner were produced using a triple-transfection, helper-free method and purified as 
described previously [14]. The titers of recombinant AAV vectors were determined by quantitative PCR: 
AAV-DIO-CK1δ, 8.8 x 1012; and AAV-DIO-mCherry, 1.0 x 1013 genome copies/ml. 
We injected the mixture of AAV-DIO-CK1δ and AAV-DIO-mCherry (ratio 5:1) into the SCN of 
eight Avp-CK1δ-/- mice so that we could evaluate the efficiency and specificity of expression by 
immunostaining of mCherry. The stereotaxic injection of AAV vectors was performed as described 
previously [14]. One week after surgery, mice started to be monitored for their locomotor activity. 
 
Histological Study 
Animals were sacrificed by transcardial perfusion of PBS followed by 4% paraformaldehyde fixative. Serial 
coronal brain sections (30 µm thick) were collected in four series. One of these was further immunostained or 
in situ hybridized. Immunostaining was performed as previously described [S2]. The AAV-mediated 
expression of mCherry was detected by staining with rabbit anti-DsRed (Clontech, 1:2000), biotinylated 
anti-rabbit antibody (Vector Labs, 1:500), and the Vectastain ABC kit (Vector Labs). Double-immunostaining 
of AVP and VIP was performed with rabbit anti-AVP (Millipore, 1:2000); goat anti-VIP (Santa Cruz, 
1:1000); Alexa 488-conjugated Donkey anti-rabbit IgG (Molecular Probes, 1:2000); and Alexa 
594-conjugated Donkey anti-goat IgG (Molecular Probes, 1:2000). 
In situ hybridization was performed as previously described using antisense riboprobes labeled with 
digoxigenin-UTP [S3]. Both CK1δflox2/flox2 and Avp-Cre;CK1δ+/flox2 were used as control mice. Antisense 
riboprobes were synthesized from plasmids containing mouse Per1 (NM_011065, nucleotides 3443-4515), 
mouse Avp (BC051997, nucleotides 337-531), and mouse CK1δ (variant 1, NM_139059, nucleotide 
435-1573) cDNAs. The mRNA expression levels were quantified by Photoshop (Adobe) as follows. First, the 
images were transformed to grayscale. Then, mean intensities of pixels within the region of interest were 
calculated. The values of the region adjacent to the SCN were regarded as background and were subtracted 
from those of the SCN. 
 
Bioluminescence Imaging 
The Avp-CK1δ1-/- mice were further mated with Per2::Luc reporter mice [17] 
(Avp-Cre;CK1δflox2/flox2;Per2::Luc) and compared to control mice (CK1δflox2/flox2;Per2::Luc). Mice aged 10 to 
17 weeks were housed in DD for 6 days before sampling. Coronal SCN slices of 150 µm were made at 
approximately CT8–9 with a vibratome (Leica, Vi1000S). The SCN tissue was dissected at the 
mid-rostrocaudal region and a paired SCN was cultured on a Millicell-CM culture insert (Millipore) in a 
sealed dish containing 1.2 mL of DMEM (Invitrogen) supplemented with 10 mM Hepes, 2.74 mM NaHCO3, 
0.1 mM D-luciferin K salt, 2% B27, and 20 mg/L kanamysin at 37°C, as described previously with slight 
modifications [33]. 
In a mini-incubator (Tokai Hit) installed on the stage of an inverted microscope (Nikon, Ti-U), 
PER2::LUC bioluminescence was measured with a 10x objective lens (N.A. 0.45; Nikon) and an EMCCD 
camera (Andor, iXon3) mounted at the bottom port of the microscope with a 0.7x relay lens. Images were 
acquired every 30 min with an exposure time of 25 min for 5 days and were analyzed using ImageJ and 
custom-made program [20]. Resolution of images was adjusted to 4.6 µm/pixel for further analyses. Circular 
regions of interest were defined in the shell and core of SCN. Bioluminescence values within the defined 
regions were detrended by subtracting 24-hr moving average values and then were smoothened with a 
five-point moving average method. Because the waveforms of luminescence from the SCN shell of 
Avp-CK1δ1-/-;Per2::Luc mice was noisy in some cases, the middle of the time points crossing value 0 upward 
and downward were defined as acrophases, and the intervals between two adjacent acrophases were 
calculated as the periods [14]. We note that very similar results were also obtained when the acrophases were 
defined as the time points with the maximal values within each cycle.  
For pixel-based analyses, we detrended PER2::LUC oscillations in individual pixels for 3 days 
(data for 72 hr from the first CT6 after slice preparation, determined according to the behavioral free-running 
period prior to slice preparation) and cosine curve-fitted them using a custom-made program [14, 20] with 
minor modifications. Pixels with non-significant Pearson correlation coefficients, shown as black pixels, were 
eliminated to calculate the mean of amplitude (peak-trough difference), period, and first acrophase (peak 
phase). Pixels with significant oscillation (p < 0.01) of periods longer than 34 hr, indicated as white pixels in 
period maps, were eliminated to calculate the mean period. For the first acrophase, “6 hr” corresponds to the 
beginning of cosine curved-fitted data (~CT6). The shell and core were defined as pixels within the dorsal 
40% or ventral 30% region for individual bilateral SCNs. 
 
Statistical Analysis 
All results are expressed as mean ± SEM. For comparisons of two groups of normally distributed data in the 
analyses of behavior rhythm, Student’s t tests were performed, whereas for comparisons of four groups of 
normally distributed data, Kruskal-Wallis tests followed by Steel-Dwass post hoc tests were performed. To 
analyze mRNA expression, two-way repeated-measures ANOVA followed by post hoc Student’s t tests or 
paired t tests were performed. For PER2::LUC imaging, two-way repeated-measures ANOVA was followed 
by post hoc tests as below. To compare the two groups, Student’s t tests or paired t tests were performed; 
Welch’s t test was used when the variances of the two groups differed significantly. To compare the three 
groups in Figure S3, Friedman tests followed by Wilcoxon signed-rank tests were performed. All p values 
less than 0.05 were considered to be statistically significant. Only relevant information from statistical 
analysis is indicated in the text, figures, and tables. Statistical analyses were performed with ANOVA4 and 
EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan). The EZR is a graphical user 
interface for R (The R Foundation for Statistical Computing, Vienna, Austria) [S4]. More precisely, it is a 
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